02/14/2025
8:00 PM | ArriVent BioPharma (Subject)
Novo Holdings A/S (Filed by)
| Form SCHEDULE 13G | |
02/03/2025
6:05 AM | ArriVent BioPharma (Filer)
| Form S-3ASR | |
01/21/2025
6:21 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | ArriVent BioPharma (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SC 13G | |
11/14/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
1:45 PM | ArriVent BioPharma (Subject)
Sofinnova Venture Partners XI, L.P. (Filed by)
| Form SC 13G | |
10/24/2024
1:02 PM | ArriVent BioPharma (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
09/23/2024
5:14 PM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
11:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
4:03 PM | ArriVent BioPharma (Filer)
| Form 8-K/A | |
07/09/2024
4:05 PM | ArriVent BioPharma (Filer)
| Form 8-K/A | |
06/05/2024
6:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
4:29 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/20/2024
4:30 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
3:05 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/23/2024
3:06 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:10 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free AVBP Stock Alerts